Medley, Inc. (TYO:4480)
Japan
· Delayed Price · Currency is JPY
3,650.00
-70.00 (-1.88%)
Feb 5, 2025, 3:30 PM JST
Medley Revenue
Medley had revenue of 6.94B JPY in the quarter ending September 30, 2024, with 44.68% growth. This brings the company's revenue in the last twelve months to 26.67B, up 38.85% year-over-year. In the year 2023, Medley had annual revenue of 20.53B with 44.74% growth.
Revenue (ttm)
26.67B
Revenue Growth
+38.85%
P/S Ratio
4.44
Revenue / Employee
24.14M
Employees
1,105
Market Cap
118.57B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 20.53B | 6.35B | 44.74% |
Dec 31, 2022 | 14.19B | 3.32B | 30.58% |
Dec 31, 2021 | 10.86B | 4.03B | 59.05% |
Dec 31, 2020 | 6.83B | 2.07B | 43.34% |
Dec 31, 2019 | 4.77B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Takeda Pharmaceutical Company | 4,579.02B |
Otsuka Holdings | 2,269.56B |
Terumo | 986.67B |
Astellas Pharma | 1,772.16B |
Olympus | 973.60B |